We are now accepting applications for new NCI CIRB members. There are openings on the boards for medical oncologists, medical oncologists with immunotherapy experience, pharmacists, ethicists, statisticians and those with Cancer Care Delivery Research (CCDR) experience. The 2019 cohort of new board members will be appointed in the fall timeframe with orientation on November 4th. New board members will assume their role on the board in January 2020. The CIRB consists of four boards, each addressing different types of trials. To learn more about each board and what areas of responsibility they cover, see About the Boards in the About section of this website.
CIRB MEMBERSHIP BASICS
- Each CIRB includes Ethicists, Nurses, Patient Advocates, Pharmacists, Physicians, and Statisticians.
- Each CIRB has a different area of specialization (see below) and may require additional board members to ensure the proper expertise is represented.
- Members serve on one of four CIRBs - refer to list below.
- Prior IRB experience is preferred, but not required.
- NCI employees and contractors are not eligible to serve on the CIRB.
- CIRB meetings are scheduled for four hours in length and are conducted via web-enhanced teleconference.
- Occasionally members are asked to serve as a consultant reviewer for other CIRBs.
CIRB MEMBER Position Description:
A CIRB Member should have the following knowledge, skills, and experience:
- Knowledge and the ability to apply the:
- Ethical principles underlying protection of study participants
- Common Rule
- Federal regulations applicable to the protection of study participants
- Ability to apply expertise to IRB role
- Strong interpersonal and communication skills
- Comfortable articulating opinions and position on a particular topic(s)
- Enjoy working in a collaborative environment
- Maintain knowledge of regulations and policies pertaining to human research
- Maintain knowledge of CIRB policies pertaining to serving as a CIRB member
- Understand the Conflict of Interest Policy for CIRB Members and disclose potential or known conflicts of interest
- Review all materials received and/or electronically posted prior to meetings
- Attend regularly scheduled CIRB meetings via teleconference and ePanel©
- Engage in discussions and vote at CIRB meetings
- When assigned, serve as primary reviewer for scheduled reviews and submit a written review of the assigned study using the appropriate reviewer form within the designated timeframe.
- Maintain confidentiality of CIRB discussions and all meeting materials
- Attend and participate in monthly board meeting educational training sessions, ad hoc webinars, and any in-person educational meetings
- Respond by indicated deadline to requests from CIRB Operations Office for information
BOARD SPECIALIZATION AND MEETING SCHEDULE
|Adult CIRB – Late Phase Emphasis||Phase 3 Cancer Treatment Trials||
|Adult CIRB - Early Phase Emphasis||Early Phase Treatment Trials||
|Cancer Prevention & Control CIRB||Cancer Prevention, Control, and Care & Delivery Research||
|Pediatric CIRB||Pediatric Treatment, Prevention, Control and Care & Delivery research||
To learn more about each board and what areas of responsibility they cover, see About the Boards in the About section of this website.
ORIENTATION & CONTINUING EDUCATION
- CIRB members participate in an orientation program designed to provide knowledge of applicable human subject protection regulations and procedures and the ability to apply the ethical principles underlying protection of study participants.
- Continuing Education participation for CIRB members is required. Training is offered throughout the year in a variety of formats which include: monthly board meetings, ad hoc webinars, and in-person education days.
Thank you for your interest in the CIRB for the National Cancer Institute. If you have any questions or would like to speak to someone, please contact us at email@example.com or call 888-657-3711.
If you are interested in becoming a board member, please refer to the following: